A trial to assess FOLFIRINOX alone, or in combination with bevacizumab or cetuximab, in patients with metastatic colorectal cancer treated in French centres

Trial Profile

A trial to assess FOLFIRINOX alone, or in combination with bevacizumab or cetuximab, in patients with metastatic colorectal cancer treated in French centres

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Cetuximab (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top